SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
218 hedge funds and large institutions have $540M invested in Sorrento Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 79 increasing their positions, 43 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $798M → $540M (-$258M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
218
Holding in Top 10
1
Calls
$90.3M
Puts
$47.9M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$8.24M | |
| 3 | +$6.6M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.63M |
| 5 |
Goldman Sachs
New York
|
+$5.04M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$6.76M | |
| 3 | -$5.42M | |
| 4 |
Millennium Management
New York
|
-$3.92M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.14M |